Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > FcRn (FCGRT & B2M) > FRT-01

Human FcRn binding Kit (TR-FRET)

For research use only.

Order Now

Product Details
Assay TypeInhibition-TR-FRET
AnalyteFcRn binding component
Format100T, 500T, 10000T
Regulatory StatusRUO
Standard Curve Range0.24 μg/mL-1000 μg/mL
Assay Time1 hr
Suitable Sample TypeFor the binding of IgG Fc region to the human FcRn receptor
Sample volume10 μL
Materials Provided
FRT01-C01Human FCRN&B2M Heterodimer Protein Europium-chelate2.7 μg/100 tests
13.5 μg/500 tests
270 μg/10000 tests
FRT01-C02FA labeled human IgG antibody2.4 μg/100 tests
12 μg/500 tests
240 μg/10000 tests
FRT01-C03Human IgG standard200 μg/100 tests
1 mg/500 tests
20 mg/10000tests
FRT01-C04Sample Dilution Buffer10 mL/100tests & 500tests
100 mL/10000tests
FRT01-C05Detection Buffer10 mL/100tests & 500tests
100 mL/10000tests
  • Background
    FcRn is a heterodimer comprising a β2-microglobulin (β2m) light chain and a major histocompatibility complex class I-like heavy chain. It is widely accepted that the interaction of IgGs with the Fc receptor (FcRn) plays a critical role in regulating IgG homeostasis in vivo. FcRn interacts with the CH2-CH3 portion of the Fc domain of IgGs in a tightly regulated pH-dependent manner with high affinity binding occurring at an acidic (pH=6) and weak to no binding interactions as the pH is raised to neutral (7.4). FcRn is responsible for the extended serum half-life of IgG and also serum albumin, and for the transport across endothelial and epithelial barriers, increasing the overall bioavailability of IgG and serum albumin. The binding affinity between FcRn and IgG are commonly used to characterize the metabolic levels of antibody drugs.

    The Human FcRn Binding Kit (TR-FRET) can detect the binding of IgG Fc region to the human FcRn receptor in homogeneous system within 0.5-1 hours. it is high sensitive, short detection time and easy to use.

  • Application

    The kit is developed for the binding of IgG Fc region to the human FcRn receptor. It is used as a universal detection tool to identifying the ability of antibody drugs to bind to FcRn.

    It is for research use only.

  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This Human FcRn binding Kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). Use the mixture of biotinylated FcRn and Europium-chelate labeled streptavidin as the donor, FA labeled Human IgG1 antibody as the acceptor. Firstly, mix the sample or Human IgG standard in the kit with Human FCRN&B2M Heterodimer Protein Europium-chelate (Donor) and incubate at room temperature for 0.5 hour. Then, add FA labeled human IgG antibody (Acceptor) and incubate at room temperature for more than 0.5 hour. Use the TR-FRET module of a microplate reader to read the fluorescence signal at 665nm and 620nm. When the sample does not contain FcRn binding component, the donor and acceptor are in close proximity because of the binding of FcRn and FA labeled Human IgG1 antibody. The 620nm signal emitted by the donor under specific light source excitation is received by the acceptor, emitting a 665nm signal. When the sample contains FcRn binding components, the components compete with the binding between the donor and acceptor and thereby prevents FRET from occurring. Calculate Ratio based on the formula Ratio = "Signal 665 nm" /" Signal 620 nm " × 10^4. The Ratio value is negatively correlated with the antibody content in the sample.

    Assay Principles

Bioactivity-TR-FRET Please refer to DS document for the assay protocol.

Inhibition of Europium-chelate labeled FcRn: FA labeled human IgG antibody binding by Human IgG
Premix serial dilutions of Human IgG standard (Catalog # FRT01-C03) (1:4 serial dilution, from 1000 μg/mL to 0.24 μg/mL (6666.67-1.63 nM)) and Human FCRN&B2M Heterodimer Protein Europium-chelate (Catalog # FRT01-C01) and incubate at room temperature (20℃-25℃) for 0.5 hour. Then add FA labeled human IgG antibody (Catalog # FRT01-C02) and incubate at room temperature (20℃-25℃) for 0.5 hour. Detection was performed with IC50 of 20.14 μg/mL. The assay was performed according to the above-described Datasheet (QC tested).


The kit has been used to detect different human IgG isoforms of Human IgG1, Human IgG2, Human IgG3, Human IgG4, and modified Human IgG1 Fc (C103S, M135Y, S137T, T139E, H316K, N317F) Protein, His Tag (Cat. No. IG1-H52H8) with different affinities binding to FcRn.

  • Clinical and Translational Updates

Comments (0)

ETA of in-stock products: 2 business days

Price(USD) : $750.00

Price(USD) : $2500.00

Promotion & Exhibitions

Drug Development Status

  • Number of Launched Drugs:3 Details
  • Number of Drugs in Clinical Trials:3 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message